2632-10-2

Basic information

• Product Name: 3,4-DICHLOROPHENACYL BROMIDE
• Synonyms: 2-Bromo-3′,4′-dichloroacetophenone,3,4-Dichlorophenacyl bromide;1-(3,4-Dichlorophenyl)-2-bromoethan-1-one;2-Bromo-1-(3,4-dichlorophenyl)ethan-1-one, 2-Bromo-3',4'-dichloroacetophenone;2-Bromo-3',4'-dichloroacetophenone 97%;3,4-DICHLOROPHECYL BROMIDE;2-BROMO-1-(3,4-DICHLOROPHENYL)ETHAN-1-ONE;2-BROMO-1-(3,4-DICHLOROPHENYL)ETHANONE;2-BROMO-3',4'-DICHLOROACETOPHENONE
• CAS NO: 2632-10-2
• Molecular Formula: C₈H₅BrCl₂O
• Molecular Weight: 267.93
• EINECS: -0
• Mol File: 2632-10-2.mol
• Article Data: 60

Chemical Properties

• Melting Point: 54 °C
• Boiling Point: 339℃
• Flash Point: 159℃
• Appearance: /
• Density: 1.695
• Vapor Pressure: 9.77E-05mmHg at 25°C
• Refractive Index: 1.596
• Storage Temp.: 2-8°C
• BRN: 511981
• CAS DataBase Reference: 3,4-DICHLOROPHENACYL BROMIDE(CAS DataBase Reference)
• NIST Chemistry Reference: 3,4-DICHLOROPHENACYL BROMIDE(2632-10-2)
• EPA Substance Registry System: 3,4-DICHLOROPHENACYL BROMIDE(2632-10-2)

Safety Data

• Hazard Codes: Xi,T
• Statements: 20/21/22-34-36/37-36/37/38-36-25
• Safety Statements: 26-27-36/37/39-36-45
• RIDADR: 1759
• WGK Germany: 3
• HazardClass: 8
• PackingGroup: III
• Hazardous Substances Data: 2632-10-2(Hazardous Substances Data)

Usage

General Description

3,4-Dichlorophenacyl bromide is a chemical compound used primarily as a reagent for the synthesis of pharmaceuticals and other organic compounds. It is a versatile building block with potential applications in pharmaceuticals, agrochemicals, and materials science. It is commonly utilized as a reagent for the protection of hydroxyl groups in organic synthesis and as an intermediate in the production of various drugs and biologically active compounds. 3,4-Dichlorophenacyl bromide is also used as a mild and selective reagent for the conversion of alcohols to their corresponding bromides, making it a valuable tool for synthetic chemists. Due to its reactivity and potential health hazards, proper safety precautions should be taken when handling and synthesizing this compound.

InChI:InChI=1/C8H5BrCl2O/c9-4-8(12)5-1-2-6(10)7(11)3-5/h1-3H,4H2

Upstream product

• 2642-63-9 3',4'-dichloroacetophenone 
• 17356-08-0 thiourea 
• 95-50-1 1,2-dichloro-benzene 

Downstream Products

• 51144-37-7 1-(3,4-dichloro-phenacyl)-pyridinium; bromide 
• 725208-27-5 1-(3,4-dichloro-phenyl)-2-(2-imino-thiazolidin-3-yl)-ethanone 
• 184530-25-4 2-amino-6-[2-(3,4-dichloro-phenyl)-2-oxo-ethylsulfanyl]-4-ethyl-pyridine-3,5-dicarbonitrile 
• 630410-86-5 [4-(3,4-dichlorophenyl)(1,3-thiazol-2-yl)][(2-nitrophenyl)methyl]amine 
• 318949-24-5 (3,4-dichloro-phenacyl)-hexamethylenetetraminium; bromide 
• 875306-52-8 C₁₀H₇Cl₂NO₃ 
• 305381-03-7 2-Chloro-5-[4-(3,4-dichloro-phenyl)-1H-imidazol-2-yl]-pyridine 

Relevant articles and documents

Anticholinesterase activity screening of some novel dithiocarbamate derivatives including piperidine and piperazine moieties

The present study was undertaken to synthesize some novel lipophilic piperazine and piperidinedithiocarbamates and investigate their inhibitory potencies against cholinesterase enzymes. In the synthetic studies, 44 new compounds were isolated. The structu

Novel BuChE-IDO1 inhibitors from sertaconazole: Virtual screening, chemical optimization and molecular modeling studies

In our effort towards the identification of novel BuChE-IDO1 dual-targeted inhibitor for the treatment of Alzheimer's disease (AD), sertaconazole was identified through a combination of structure-based virtual screening followed by MM-GBSA rescoring. Preliminary chemical optimization was performed to develop more potent and selective sertaconazole analogues. In consideration of the selectivity and the inhibitory activity against target proteins, compounds 5c and 5d were selected for the next study. Further modification of compound 5c led to the generation of compound 10g with notably improved selectivity towards BuChE versus AChE. The present study provided us with a good starting point to further design potent and selective BuChE-IDO1 inhibitors, which may benefit the treatment of late stage AD.

Chiral Bidentate Phosphoramidite-Pd Catalyzed Asymmetric Decarboxylative Dipolar Cycloaddition for Multistereogenic Tetrahydrofurans with Cyclic N-Sulfonyl Ketimine Moieties

An asymmetric [3 + 2] cycloaddition of vinyl ethylenecarbonates (VECs) and (E)-3-arylvinyl substituted benzo[d] isothiazole 1,1-dioxides has been developed using the Pd complex of a bidentate phosphoramidite (Me-BIPAM) as the catalyst, providing a wide variety of chiral multistereogenic vinyltetrahydrofurans in good yields with excellent diastereo- and enantioselectivities (up to >20:1 dr, 99% ee).